Canaccord Genuity is pleased to announce that on January 10, 2020, it completed a public offering of common stock for SeaSpine Holdings Corporation (NASDAQ: SPNE) (the “Company”). The Company issued a total of 7,820,000 shares of its common stock at a price to the public of $12.50 per share, which includes the full exercise of the underwriters’ overallotment option. The gross proceeds to the Company, before deducting the underwriting discounts and commissions and estimated offering expenses, were approximately $97.8 million. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes. A portion of the net proceeds from the offering may also be used to fund possible investments in or acquisitions of complementary businesses, products or technologies.
Canaccord Genuity acted as Joint Bookrunning Manager for the offering.
SeaSpine Holdings Corporation designs, develops and commercializes surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine.
Canaccord Genuity is focused on the corporate finance needs associated with growth companies in the United States, Canada, Europe and Asia. We are structured to provide our clients with a full range of global investment banking services, including corporate finance, research, sales and trading. Our thematic research focusing on companies around the world provides our firm with unique access to growth investors. In the last twelve months, the firm executed 185 public financings that raised approximately $32.8 billion and advised on 83 M&A assignments.
How can we help?
If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.